Fluorodeoxyglucose F18

"Fluorodeoxyglucose F18" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The compound is given by intravenous injection to do POSITRON-EMISSION TOMOGRAPHY for the assessment of cerebral and myocardial glucose metabolism in various physiological or pathological states including stroke and myocardial ischemia. It is also employed for the detection of malignant tumors including those of the brain, liver, and thyroid gland. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1162)

Descriptor ID	D019788
MeSH Number(s)	D09.254.229.500
Concept/Terms	Fluorodeoxyglucose F18 Fluorodeoxyglucose F18 F18, Fluorodeoxyglucose 18F-FDG Fluorodeoxyglucose F 18 F 18, Fluorodeoxyglucose Fludeoxyglucose F 18 F 18, Fludeoxyglucose Fluorine-18-fluorodeoxyglucose Fluorine 18 fluorodeoxyglucose 18F Fluorodeoxyglucose Fluorodeoxyglucose, 18F 18FDG 2-Fluoro-2-deoxy-D-glucose 2-Fluoro-2-deoxy-D-glucose 2 Fluoro 2 deoxy D glucose 2-Fluoro-2-deoxyglucose 2 Fluoro 2 deoxyglucose

Below are MeSH descriptors whose meaning is more general than "Fluorodeoxyglucose F18".

Chemicals and Drugs [D]
Carbohydrates [D09]
Deoxy Sugars [D09.254]
Deoxyglucose [D09.254.229]
Fluorodeoxyglucose F18 [D09.254.229.500]

Below are MeSH descriptors whose meaning is related to "Fluorodeoxyglucose F18".

Below are MeSH descriptors whose meaning is more specific than "Fluorodeoxyglucose F18".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Fluorodeoxyglucose F18" by people in this website by year, and whether "Fluorodeoxyglucose F18" was a major or minor topic of these publications.

Bar chart showing 16 publications over 13 distinct years, with a maximum of 2 publications in 2008 and 2012 and 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	0	1	1
2004	0	1	1
2007	1	0	1
2008	1	1	2
2012	0	2	2
2014	1	0	1
2016	0	1	1
2017	1	0	1
2018	0	1	1
2019	2	0	2
2020	1	0	1
2021	1	0	1
2025	1	0	1

Below are the most recent publications written about "Fluorodeoxyglucose F18" by people in Profiles.

Venables M, Taylor A, Murdoch J, De Sousa JL, Keen H. Use of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosing giant cell arteritis in a Western Australian tertiary centre: a 36-month analysis. Intern Med J. 2025 08; 55(8):1308-1315.

View in: PubMed
Nautiyal A, Mondal T, Mitra D, Goel A, Dey SK, Kaushik A. A SIMPLE AND NOVEL APPROACH TO STUDY KINETICS AND ESTIMATE RADIATION DOSES FROM INTERNALLY ADMINISTERED RADIOPHARMACEUTICALS USING AN EXTERNAL DOSE MEASUREMENT SYSTEM. Radiat Prot Dosimetry. 2021 Nov 12; 196(3-4):141-152.

View in: PubMed
Lopes NB, Almeida IV, Lopes PHS, Vicentini VEP. Radioprotective efficacy of plastic polymer against the toxicogenomic effects of radiopharmaceutical 18F-FDG on human lymphocytes. Radiat Oncol. 2020 Jun 17; 15(1):154.

View in: PubMed
Mondal T, Nautiyal A, Agrawal M, Mitra D, Goel A, Kumar Dey S. 18F-FDG-induced DNA damage, chromosomal aberrations, and toxicity in V79 lung fibroblast cells. Mutat Res Genet Toxicol Environ Mutagen. 2019 Nov; 847:503105.

View in: PubMed
Nautiyal A, Mondal T, Mukherjee A, Mitra D, Kaushik A, Goel HC, Goel A, Dey SK. Quantification of DNA damage in patients undergoing non-contrast and contrast enhanced whole body PET/CT investigations using comet assay and micronucleus assay. Int J Radiat Biol. 2019 06; 95(6):710-719.

View in: PubMed
Davies FE, Rosenthal A, Rasche L, Petty NM, McDonald JE, Ntambi JA, Steward DM, Panozzo SB, van Rhee F, Zangari M, Schinke CD, Thanendrarajan S, Walker B, Weinhold N, Barlogie B, Hoering A, Morgan GJ. Treatment to suppression of focal lesions on positron emission tomography-computed tomography is a therapeutic goal in newly diagnosed multiple myeloma. Haematologica. 2018 06; 103(6):1047-1053.

View in: PubMed
Rasche L, Angtuaco E, McDonald JE, Buros A, Stein C, Pawlyn C, Thanendrarajan S, Schinke C, Samant R, Yaccoby S, Walker BA, Epstein J, Zangari M, van Rhee F, Meissner T, Goldschmidt H, Hemminki K, Houlston R, Barlogie B, Davies FE, Morgan GJ, Weinhold N. Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma. Blood. 2017 07 06; 130(1):30-34.

View in: PubMed
McDonald JE, Kessler MM, Gardner MW, Buros AF, Ntambi JA, Waheed S, van Rhee F, Zangari M, Heuck CJ, Petty N, Schinke C, Thanendrarajan S, Mitchell A, Hoering A, Barlogie B, Morgan GJ, Davies FE. Assessment of Total Lesion Glycolysis by 18F FDG PET/CT Significantly Improves Prognostic Value of GEP and ISS in Myeloma. Clin Cancer Res. 2017 04 15; 23(8):1981-1987.

View in: PubMed
Zhu HJ, Clark LN, Deloney LA, McDonald JE. Grover disease (transient acantholytic dermatosis) in acute myeloid leukemia on FDG PET/CT. Clin Nucl Med. 2014 Feb; 39(2):e173-5.

View in: PubMed
Linnman C, Zeidan MA, Furtak SC, Pitman RK, Quirk GJ, Milad MR. Resting amygdala and medial prefrontal metabolism predicts functional activation of the fear extinction circuit. Am J Psychiatry. 2012 Apr; 169(4):415-23.

View in: PubMed

People

Explore

Similar Concepts

Top Journals